Yfantopoulos John, Protopapa Marianna, Mantalias Konstantinos, Chantzaras Athanasios, Koutsogianni Katerina, Yfantopoulos Platonas, Vassilopoulos Dimitrios
Professor of Health Economics, MBA-Health, National and Kapodistrian University of Athens, Greece.
MBA-Health, National and Kapodistrian University of Athens, Greece.
Mediterr J Rheumatol. 2020 Jun 11;31(Suppl 1):152-162. doi: 10.31138/mjr.31.1.152. eCollection 2020 Jun.
The aim of this study was to explore the beliefs of rheumatologists and patients about treatment-related factors, long-term adherence, and their communication with regard to rheumatic diseases.
In a multicentre, observational study conducted in Greece, a structured questionnaire was administered to 75 rheumatologists and 398 rheumatic patients from different regions. Five domains were investigated: i) effectiveness of treatment, ii) choice of treatment, iii) change of ineffective treatment, iv) long-term adherence, and v) the quality of communication between doctors and patients. Descriptive data, confidence intervals, t-tests and factor analysis were employed.
Examining the patients' and rheumatologists' beliefs and attitudes about treatment profiles and long-term adherence, a statistically significant convergence in their views on effectiveness and safety as the predominant factors concerning choice of treatment and long-term adherence was found. Although patients reported high trust to their doctors, a divergence of views is recorded regarding communication of the two parts. Statistically significant differences in the views between patients and rheumatologists were found with regards to access (p<0.001), time per visit (p<0.001), mutual understanding (p<0.001), and overall communication (p<0.001).
Our study shows a great rate of agreement between patients and rheumatologists regarding the factors determining the efficacy, choice, switching and adherence to treatment while there was significant divergence in the views regarding the quality of communication between the two parts. Co-ordinated efforts are needed in order to improve the communication level between rheumatic patients and rheumatologists.
本研究旨在探讨风湿病学家和患者对治疗相关因素、长期依从性以及他们在风湿性疾病方面沟通情况的看法。
在希腊进行的一项多中心观察性研究中,对来自不同地区的75名风湿病学家和398名风湿性疾病患者进行了结构化问卷调查。调查了五个领域:i)治疗效果,ii)治疗选择,iii)无效治疗的更换,iv)长期依从性,以及v)医患沟通质量。采用描述性数据、置信区间、t检验和因子分析。
研究患者和风湿病学家对治疗方案和长期依从性的看法及态度时发现,他们在将有效性和安全性视为治疗选择和长期依从性的主要因素这一观点上存在统计学上的显著趋同。尽管患者表示对医生高度信任,但在双方沟通方面仍存在观点分歧。在就诊机会(p<0.001)、每次就诊时间(p<0.001)、相互理解(p<0.001)和整体沟通(p<0.001)方面,患者和风湿病学家的观点存在统计学上的显著差异。
我们的研究表明,患者和风湿病学家在决定治疗疗效、选择、更换和依从性的因素方面达成了很高的一致率,但在双方沟通质量的观点上存在显著分歧。需要共同努力以提高风湿性疾病患者和风湿病学家之间的沟通水平。